Ophthalmology · Houston, TX
NPI
1124282983
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1919 North Loop W Ste 100
Houston, TX, 77008
Phone (713) 715-7099
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
122 services
Medicare patients, 2024
52
Average age 73
Drug cost, 2024
$1.2M
1,461 prescriptions
Company payments, 2025
$201K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elvia Canseco was code 99213 (office e&m - established), 26 times for 22 patients. In total Elvia Canseco billed 122 services in 21 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 26 | 22 | $49.59 | $1,289 |
| 68761 Eye | Office | 23 | 12 | $77.97 | $1,793 |
| 99214 Office E&M - Established | Office | 11 | 11 | $30.18 | $332 |
By year: 2022 $39K for 371 services; 2023 $95K for 772 services; 2024 $19K for 122 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elvia Canseco prescribed most often to Medicare patients was Xdemvy (Lotilaner), with 502 prescriptions and refills. In total Elvia Canseco wrote 1,461 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xdemvy Lotilaner | 502 | 714 | 469 | $984K |
| Prednisolone Acetate Generic | 223 | 238 | 153 | $7,445 |
| Moxifloxacin Moxifloxacin Hcl | 175 | 175 | 113 | $5,463 |
| Ketorolac Tromethamine Generic | 139 | 157 | 89 | $3,431 |
| Lumigan Bimatoprost | 97 | 185 | 46 | $46K |
| Latanoprost Generic | 66 | 150 | 31 | $656 |
| Restasis Cyclosporine | 60 | 118 | 39 | $74K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 27 | 44 | 11 | $332 |
| Cyclosporine Generic | 17 | 27 | Under 11 | $10K |
| Timolol Maleate Generic | 17 | 40 | Under 11 | $205 |
| Azelastine Hcl Generic | 16 | 26 | 12 | $660 |
| Bromfenac Sodium Generic | 14 | 17 | Under 11 | $2,221 |
| Valacyclovir Valacyclovir Hcl | 13 | 21 | Under 11 | $676 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 12 | 25 | Under 11 | $3,377 |
Brand drugs: 989 claims; generic drugs: 472 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elvia Canseco $201K ($201K in general payments such as food, travel and fees) from 10 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $153K.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 131 | $153K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 41 | $37K |
| Glaukos Corporation GKOS | 10 | $9,352 |
| Abbvie Inc. ABBV | 2 | $1,431 |
| Carl Zeiss Meditec USA, Inc. | 4 | $335 |
| Bausch & Lomb Americas Inc. BLCO | 4 | $205 |
| Alcon Vision LLC ALC | 3 | $204 |
| Rayner Intraocular Lenses Limited | 1 | $188 |
| Sight Sciences, Inc. SGHT | 2 | $167 |
| Lumibird Medical Inc. | 1 | $73.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.